Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery

Summary

The purpose of this study was to determine the safety of ranibizumab: a) as a surgical adjunct during cataract surgery in subjects with proliferative diabetic retinopathy (PDR) induced rubeosis and, b) in treatment of proliferative diabetic retinopathy (PDR).

Timeline

Start

2007-07

Primary completion

2011-12

Completion

2012-01

Drugs

Indications